TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
LQDA

Liquidia Technologies Inc

Healthcare · Drug Manufacturers - Specialty & Generic

68.40$ -3.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow LQDA
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-105.5% -334.7% -1,175.9% -598.1% -7,320.5% -264.8% -179.4% -237.7% -667.5% -22.5%
4.9% 12.8% 57.0% 31.8% 423.1% 43.7% 22.9% 12.5% 15.7% 1.0%
2.6% 7.1% 81.1% 41.8% 534.6% 52.5% 58.3% 57.7% 134.4% 18.6%
5.6% -86.7% 70.8% 41.9% 559.6% 56.9% 68.6% – – –
4.5% 5.4% 10.9% -86.1% -231.4% -96.3% -13.5% 33.6% -34.2% -15.3%
21.8% 35.1% 32.2% 22.9% 101.7% 0.8% 3.7% 7.4% 35.4% 2.7%
-21.8% -35.1% -32.2% -22.9% 33.5% -0.8% -3.7% -64.5% -60.3% -4.0%
3.4% 1.3% 2,688.0% 773.4% – – – – – –
42.9% 414.9% -52.7% 49.6% -915.2% -3.3% 56.2% 101.3% 375.1% 34.0%
46.2% 397.0% 2,542.2% 822.5% 8,574.1% 204.8% 407.7% 247.3% 1,390.8% 37.7%
-81.1% 27.3% 1,334.2% 201.5% 1,287.1% -60.9% 224.6% -54.9% 663.0% 9.0%
-127.4% -369.7% -1,208.0% -621.1% -7,422.2% -265.6% -183.1% -245.0% -702.9% -25.3%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?